Eliot A Brinton

Correction: An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway

Daniel A Beard, James Lu, Katrin Hü Bner, 2014, PLoS Comput. Biol..

Safety of anacetrapib in patients with or at high risk for coronary heart disease.

Christopher P Cannon, Eliot A Brinton, A. Gotto, 2010, The New England journal of medicine.

Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education.

Matthew K Ito, Eliot A Brinton, Matthew K. Ito, 2013, Journal of clinical lipidology.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Eliot A Brinton, Vivian A Fonseca, K. Wyne, 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

Matthew K Ito, Eliot A Brinton, Matthew K. Ito, 2012, Journal of clinical lipidology.

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.

A Lawrence Gould, Christopher P Cannon, Bruce Binkowitz, 2009, American heart journal.